P-Anisic Acid

P-Anisic Acid

SCHEMBL2903597

COc1ccc(C(=O)O)cc1.N#Cc1ccccc1-c1ccccc1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
CES2 O00748 1/20 0.51
CES1 P23141 1/20 0.51
TAS2R14 Q9NYV8 1/20 0.51
ALDH1A1 P00352 2/20 0.49
KDM4E B2RXH2 1/20 0.49
MEN1 O00255 1/20 0.49
CYP1A2 P05177 1/20 0.49
GLA P06280 1/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
HPGD P15428 1/20 0.49
CYP2C19 P33261 1/20 0.49
GFER P55789 1/20 0.49
KMT2A Q03164 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
PRKAB2 O43741 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2039846 0.85 ESR2 (0.62) CES2CES1FFAR1AKR1B1
Benzoic Acid SCHEMBL8919114 0.85 ESR2 (0.58) CES2CES1FFAR1AKR1B1
SCHEMBL6951995 0.83 ESR2 (0.59) NPC1RAB9AALDH1A1KDM4EMEN1
SCHEMBL29020924 0.82 CA1 (0.71) CA1CA2NPC1RAB9ACES2
SCHEMBL29788308 0.82 CYP2C8 (0.56) CA1CA2KDM4ESMN1; SMN2PRKAB2
SCHEMBL2041742 0.82 CYP2C8 (0.56) CA1CA2KDM4ESMN1; SMN2PRKAB2
SCHEMBL2043860 0.79 CYP2C8 (0.47)
P-Anisic Acid SCHEMBL9665587 0.78 CA1 (0.77) CA1CA2NPC1RAB9ACES2
Trifluoroacetic Acid SCHEMBL3107501 0.77 PTPN5 (0.56) FFAR1AKR1B1
Benzoic Acid SCHEMBL5166939 0.77 ESR2 (0.49) CES2CES1FFAR1AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751589-B1 METHOD OF MANUFACTURE OF MULTILAYER CHOLESTERIC LIQUID CRYSTAL OPTICAL BODIES 3M INNOVATIVE PROPERTIES CO (US) 2010-08-04 EP disclosed
US-7510741-B2 Method of making multilayer cholesteric liquid crystal optical bodies 3M INNOVATIVE PROPERTIES COMPANY (US) 2009-03-31 US disclosed
EP-1751589-A1 METHOD OF MANUFACTURE OF MULTILAYER CHOLESTERIC LIQUID CRYSTAL OPTICAL BODIES 3M Innovative Properties Company (US) 2007-02-14 EP disclosed
WO-2005119311-A1 METHOD OF MANUFACTURE OF MULTILAYER CHOLESTERIC LIQUID CRYSTAL OPTICAL BODIES 3M INNOVATIVE PROPERTIES COMPANY (US) 2005-12-15 WO disclosed
US-20050266158-A1 Multilayer cholesteric liquid crystal optical bodies and methods of manufacture and use 3M INNOVATIVE PROPERTIES COMPANY 2005-12-01 US disclosed